Success Story: NIW Approved Without RFE for an Organic Chemistry Researcher
On May 26th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Researcher in the Field of Organic Chemistry (Approval Notice).
General Field: Organic Chemistry
Position at the Time of Case Filing: Graduate Researcher
Country of Origin: China
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: May 26th, 2026
Processing Time: 20 months, 1 day
Case Summary:
The synthesis of complex natural products sits at the frontier of modern pharmaceutical discovery, and few areas hold more promise for combating life-threatening diseases like cancer. The client was a graduate researcher specializing in organic chemistry, with a research focus on advancing the discovery and development of innovative pharmaceuticals through new synthetic methodologies and the synthesis of unique bioactive molecules to combat human diseases such as cancer, bacterial infections, and diabetes.
Our team approached this filing with a case-by-case strategy, carefully analyzing the client's background to build a cohesive narrative under the NIW framework. Rather than simply listing credentials, we constructed arguments around three pillars: the substantial merit and national importance of the client's proposed endeavor, the client's demonstrated ability to advance that endeavor through a documented record of impactful research, and the broader national benefit of waiving the job offer requirement to allow this cutting-edge work to continue unimpeded.
A key element of our strategy was grounding the national importance argument in concrete, real-world stakes. We demonstrated that cancer remains one of the leading causes of death in the United States, representing a significant and growing burden on the national healthcare system, and that the client's innovative approach to synthesizing novel bioactive molecules directly addressed this critical public health need. We further highlighted that the U.S. is the global leader in pharmaceutical R&D, and that the client's synthetic chemistry work supported and accelerated the drug discovery pipeline at a time of urgent national need.
We organized the supporting evidence to give USCIS a clear and verifiable picture of the client's expertise and influence:
- Publication record: 8 peer-reviewed journal articles (3 of them first-authored)
- Scientific influence: 111 citations
- Funding: Research supported by the National Institutes of Health and the National Science Foundation
- Education: B.S. in chemistry
We also submitted four letters of recommendation from experts in the field. One independent expert stated:
"[Client]'s expertise in designing and executing intricate chemical synthesis techniques has been of great significance to the field of organic chemistry. His work on complex natural products has translational benefits for the treatment of diseases such as aggressive cancers."
USCIS approved the NIW petition in over 20 months without an RFE. We are proud to have supported the client throughout this journey and look forward to seeing the continued impact of their work in advancing organic chemistry and pharmaceutical innovation in the United States.